Cameron S. Carter, M.D.

Cameron S. Carter, M.D.
Philosophy of Care
Dr. Carter's philosophy of care includes early intervention, multidisciplinary team approach, family
systems perspective.
Clinical Interests
Cameron S. Carter's clinical interest is the early diagnosis and treatment of schizophrenia and other
cognitive mental disorders. His research focuses on the pathophysiology of disturbances in
cognition in mental disorders such as schizophrenia and OCD, with the goal of developing more
effective therapies to improve patients' chances of rehabilitation. Carter also is involved in
development of new treatments for cognitive disability in schizophrenia and other brain disorders.
A key element of the philosophy of his lab is that good clinical research can proceed only if it is
being constantly informed by ongoing theoretical and methodological progress in basic cognitive
neuroscience, and that the experiments of nature provided by clinical brain disorders may lead to
powerful additional insights into the neural basis of normal cognition.
Professor of Psychiatry and Psychology
Director, Imaging Research Center
Director, EDAPT Clinic
Director, Schizophrenia Research and Education Program
Director, Center for Neuroscience
Director, Behavioral Health Center of Excellence
Director and Principal Investigator, UC Davis Conte Center
Center/Program Affiliation
Psychiatry and Behavioral Sciences
Imaging Research Center
Psychiatry Department, 2230 Stockton Blvd. Sacramento, CA 95817
Phone: 916-734-3574
Additional Phone
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
M.D., University of Western Australia, Perth, Crawley, 1979
B.S., University of Western Australia, Crawley, 1975
Flinders Medical Center, Adelaide, 1981-82
Cameron S. Carter, M.D.
Flinders Medical Center, Adelaide, 1982
University of California Davis Medical Center, Sacramento, California, 1985-89
Veterans Administrative Medical Center, Martinez, California, 1985-89
Board Certifications
Professional Memberships
University of California Davis Medical Center, Sacramento, California, 1988-89
American Board of Psychiatry and Neurology, 1992
American College of Neuropsychopharmacology
American Psychiatric Association
Organization for Human Brain Mapping
Society for Biological Psychiatry
Society for Cognitive Neuroscience
Society for Neuroscience
Honors and Awards
Dean’s Award for Excellence in Community Engagement, 2008
NARSAD Distinguished Investigator Award, 2007
Dean’s Excellence in Mentoring Award, UC Davis School of Medicine, 2006
Elected to the American College of Neuropsychopharmacology, 2003
NARSAD Klerman Award for Outstanding Clinical Research Achievement, 2001
NIMH Independent Scientist Career Award (K02), 2001
Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, 2001
Honorable Mention, Klerman Award for Outstanding Clinical Research by a NARSAD Young
Investigator, 1998
NARSAD Young Investigator Award, 1997
NARSAD Young Investigator Award, 1994
NIHM NCDEU Young Investigator Travel Award, 1993
Northern California Psychiatric Association Resident Recognition Award for Clinical Excellence in
Psychiatry, 1989
Friendly Societies Prize for Medicine, 1973
Convocation Prize for Medicine, 1973
Select Recent Publications
To view Dr. Carter's publications, please click here.
Carter CS, Bullmore, E.T., Harrison, P. Is there a Flame in the Brain in Psychosis? Biological
Psychiatry 75(4):258-9.
Cameron S. Carter, M.D.
Ragland JD, Ranganath C, Harms MP, Barch DM, Gold JM, Layher E, Lesh TA, MacDonald AW
3rd, Niendam TA, Phillips J, Silverstein SM, Yonelinas AP, Carter CS. Functional and
Neuroanatomic Specificity of Episodic Memory Dysfunction in Schizophrenia: A Functional
Magnetic Resonance Imaging Study of the Relational and Item-Specific Encoding Task. JAMA
Psychiatry. 2015 Jul 22.
Solomon M, Yoon JH, Niendam TA, Ragland JD, Lesh TA, Fairbrother W, Carter CS. The
development of the neural substrates of cognitive control in adolescents with autism spectrum
disorders. Biological Psychiatry. 2013;76(5):412-21.
Minzenberg MJ, Carter CS. Developing treatments for impaired cognition in schizophrenia. Trends
in Cognitive Science. 2012;16:35-42.
Minzenberg MJ, Firl A, Yoon J, Gomes G, Rienking C, Carter CS. Gamma oscillatory power is
impaired during cognitive control independent of medication status in first episode schizophrenia.
Neuropsychopharmacology. 2010;35:2590-9.
Minzenberg MJ, Watrous AJ, Yoon JH, Ursu S, Carter CS. Modafinil shifts human locus coeruleus
to low-tonic, high phasic activity during functional MRI. Science. 2008;322(4908):1700-1702.
Kerns JG, Cohen JD, MacDonald AW, III, Cho R., Stenger VA, Carter CS. Anterior cingulate
conflict monitoring and adjustments in control. Science. 2004;303, 1023-1026.
© 2016 UC Regents